Radnet acquires See-Mode technologies for access, revenue growth

Radnet acquires See-Mode technologies for access, revenue growth

1 minute, 35 seconds Read

Diagnostic image company Radnet, via Deephealth, his entire subsidiary, has taken over AI Ultrasound Imaging Company See-fashion Technologies.

See modes AI-driven ultrasonic detection, characterization and reporting application for thyroid gland and breast will be integrated into the supply of Deephealth Population Health in Radnet.

According to Radnet, the original applications of See mode for detecting and characterizing thyroid nodules and breast lesions in ultrasound image formation “Improve diagnostic accuracy and improve clinical workflows by generating standardized reports.”

“Early implementation of see-mode’s FDA-approved thyroid ultrasound AI in some of our imaging centers has shown 30% to reduce the scanning time as a result of increased workflow efficiency of SEE-MODE’s automated detection and reporting,” Dr. Howard Berger, President and CEO of Radnet, said in a statement.

“With the question that exceeds the available arrangement slots for many of our more than 900 ultrasound units, the increase in capacity created by See-Mode would improve our ability to stimulate better access and more income through Radnet’s existing centers.”

The larger trend

In 2024, Healthcare and Deephealth Worked together on an AI image formation technology to further innovation, commercialization, commercialization and acceptance.

As part of the cooperation, the companies said they would develop smart technological solutions that use the power of AI to tackle obstacles in the imaging value chain, such as the interpretation efficiency of the imaging, reporting and facilitating cooperation between care teams, improving clinical efficiency and product of images of images of images.

In 2022, Volpara Health Technologies A user contract signed With Radnet for the implementation of Volpara Analytics and Volpara Risk Pathways software on the 353 Imaging Centers of Radnet in seven American states. In 2024, see-mode obtained 510 (K) Clearance Of the FDA for an AI-driven range to detect and diagnose thyroid problems in ultrasound scans.

A year earlier, see-fashion obtained Regulatory approvals In Australia and New Zealand for its AI-driven breast and thyroid ultrasound offer.

#Radnet #acquires #SeeMode #technologies #access #revenue #growth

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *